annual EBITDA:
-$43.00M+$3.53M(+7.59%)Summary
- As of today (July 4, 2025), AVXL annual EBITDA is -$43.00 million, with the most recent change of +$3.53 million (+7.59%) on September 30, 2024.
- During the last 3 years, AVXL annual EBITDA has fallen by -$5.36 million (-14.24%).
- AVXL annual EBITDA is now -296465.52% below its all-time high of -$14.50 thousand, reached on September 30, 2004.
Performance
AVXL EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$12.42M+$1.16M(+8.56%)Summary
- As of today (July 4, 2025), AVXL quarterly EBITDA is -$12.42 million, with the most recent change of +$1.16 million (+8.56%) on March 31, 2025.
- Over the past year, AVXL quarterly EBITDA has dropped by -$265.00 thousand (-2.18%).
- AVXL quarterly EBITDA is now -3529.16% below its all-time high of $362.10 thousand, reached on December 31, 2013.
Performance
AVXL quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$50.02M-$265.00K(-0.53%)Summary
- As of today (July 4, 2025), AVXL TTM EBITDA is -$50.02 million, with the most recent change of -$265.00 thousand (-0.53%) on March 31, 2025.
- Over the past year, AVXL TTM EBITDA has dropped by -$5.04 million (-11.21%).
- AVXL TTM EBITDA is now -1219948.78% below its all-time high of -$4100.00, reached on December 31, 2004.
Performance
AVXL TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
AVXL EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7.6% | -2.2% | -11.2% |
| 3 y3 years | -14.2% | -7.8% | -17.6% |
| 5 y5 years | -49.3% | -61.3% | -68.4% |
AVXL EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -14.2% | +9.7% | -21.6% | +19.1% | -15.1% | +7.0% |
| 5 y | 5-year | -49.3% | +9.7% | -65.4% | +19.1% | -68.4% | +7.0% |
| alltime | all time | <-9999.0% | +9.7% | -3529.2% | +19.1% | <-9999.0% | +7.0% |
AVXL EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$12.42M(-8.6%) | -$50.02M(+0.5%) |
| Dec 2024 | - | -$13.58M(+15.6%) | -$49.76M(+4.6%) |
| Sep 2024 | -$43.00M(-7.6%) | -$11.74M(-4.4%) | -$47.55M(+3.3%) |
| Jun 2024 | - | -$12.28M(+1.1%) | -$46.02M(+2.3%) |
| Mar 2024 | - | -$12.15M(+6.8%) | -$44.98M(+0.1%) |
| Dec 2023 | - | -$11.38M(+11.4%) | -$44.92M(-8.1%) |
| Sep 2023 | -$46.53M(-2.3%) | -$10.21M(-9.2%) | -$48.90M(-7.3%) |
| Jun 2023 | - | -$11.24M(-7.1%) | -$52.77M(-1.9%) |
| Mar 2023 | - | -$12.09M(-21.3%) | -$53.81M(+1.1%) |
| Dec 2022 | - | -$15.36M(+9.1%) | -$53.24M(+7.3%) |
| Sep 2022 | -$47.62M(+26.5%) | -$14.08M(+14.7%) | -$49.60M(+14.1%) |
| Jun 2022 | - | -$12.28M(+6.6%) | -$43.47M(+2.2%) |
| Mar 2022 | - | -$11.52M(-1.7%) | -$42.54M(+6.4%) |
| Dec 2021 | - | -$11.72M(+47.5%) | -$39.97M(+6.2%) |
| Sep 2021 | -$37.64M(+21.7%) | -$7.95M(-30.0%) | -$37.64M(+1.2%) |
| Jun 2021 | - | -$11.36M(+27.0%) | -$37.20M(+9.6%) |
| Mar 2021 | - | -$8.94M(-4.8%) | -$33.95M(+3.8%) |
| Dec 2020 | - | -$9.40M(+25.2%) | -$32.71M(+5.7%) |
| Sep 2020 | -$30.94M(+7.4%) | -$7.51M(-7.4%) | -$30.94M(+4.2%) |
| Jun 2020 | - | -$8.11M(+5.3%) | -$29.70M(+3.6%) |
| Mar 2020 | - | -$7.70M(+0.9%) | -$28.67M(-1.3%) |
| Dec 2019 | - | -$7.63M(+21.6%) | -$29.03M(+0.8%) |
| Sep 2019 | -$28.81M(+50.2%) | -$6.27M(-11.3%) | -$28.81M(+1.6%) |
| Jun 2019 | - | -$7.07M(-12.3%) | -$28.35M(+9.8%) |
| Mar 2019 | - | -$8.07M(+9.0%) | -$25.82M(+14.8%) |
| Dec 2018 | - | -$7.40M(+27.3%) | -$22.49M(+17.2%) |
| Sep 2018 | -$19.18M(+23.5%) | -$5.81M(+28.0%) | -$19.18M(+3.4%) |
| Jun 2018 | - | -$4.54M(-4.0%) | -$18.55M(+5.1%) |
| Mar 2018 | - | -$4.73M(+15.7%) | -$17.64M(+6.9%) |
| Dec 2017 | - | -$4.09M(-21.0%) | -$16.50M(+6.2%) |
| Sep 2017 | -$15.54M(+0.6%) | -$5.18M(+42.4%) | -$15.54M(-8.1%) |
| Jun 2017 | - | -$3.64M(+1.2%) | -$16.92M(+9.0%) |
| Mar 2017 | - | -$3.59M(+14.6%) | -$15.53M(+10.2%) |
| Dec 2016 | - | -$3.13M(-52.2%) | -$14.09M(-5.3%) |
| Sep 2016 | -$15.45M(+28.3%) | -$6.55M(+191.9%) | -$14.88M(-13.6%) |
| Jun 2016 | - | -$2.25M(+4.3%) | -$17.21M(+4.4%) |
| Mar 2016 | - | -$2.15M(-45.1%) | -$16.48M(+8.5%) |
| Dec 2015 | - | -$3.92M(-55.9%) | -$15.19M(+26.8%) |
| Sep 2015 | -$12.04M | -$8.89M(+488.0%) | -$11.97M(+172.4%) |
| Jun 2015 | - | -$1.51M(+76.3%) | -$4.40M(+13.2%) |
| Mar 2015 | - | -$858.10K(+20.9%) | -$3.88M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | - | -$709.50K(-46.1%) | -$4.04M(+36.1%) |
| Sep 2014 | -$2.97M(-18.6%) | -$1.32M(+31.6%) | -$2.97M(-35.9%) |
| Jun 2014 | - | -$1.00M(-1.3%) | -$4.63M(+22.9%) |
| Mar 2014 | - | -$1.01M(-379.9%) | -$3.77M(+32.5%) |
| Dec 2013 | - | $362.10K(-112.2%) | -$2.84M(-22.1%) |
| Sep 2013 | -$3.65M(-54.8%) | -$2.98M(+2072.7%) | -$3.65M(+172.6%) |
| Jun 2013 | - | -$137.10K(+53.4%) | -$1.34M(-76.5%) |
| Mar 2013 | - | -$89.40K(-79.8%) | -$5.69M(-11.3%) |
| Dec 2012 | - | -$442.80K(-33.8%) | -$6.42M(-20.5%) |
| Sep 2012 | -$8.06M(+30.7%) | -$669.10K(-85.1%) | -$8.07M(+4.7%) |
| Jun 2012 | - | -$4.49M(+450.7%) | -$7.71M(+60.9%) |
| Mar 2012 | - | -$815.10K(-61.1%) | -$4.79M(-19.4%) |
| Dec 2011 | - | -$2.09M(+579.5%) | -$5.94M(+13.9%) |
| Sep 2011 | -$6.17M(+9.3%) | -$308.10K(-80.4%) | -$5.21M(-24.1%) |
| Jun 2011 | - | -$1.57M(-20.1%) | -$6.87M(+4.1%) |
| Mar 2011 | - | -$1.97M(+43.9%) | -$6.60M(+4.5%) |
| Dec 2010 | - | -$1.37M(-30.4%) | -$6.31M(+17.1%) |
| Sep 2010 | -$5.65M(+19.3%) | -$1.96M(+50.7%) | -$5.39M(+3.1%) |
| Jun 2010 | - | -$1.30M(-22.4%) | -$5.23M(+0.9%) |
| Mar 2010 | - | -$1.68M(+279.2%) | -$5.18M(+21.3%) |
| Dec 2009 | - | -$442.90K(-75.4%) | -$4.27M(-9.8%) |
| Sep 2009 | -$4.73M(-10.2%) | -$1.80M(+43.3%) | -$4.73M(-15.8%) |
| Jun 2009 | - | -$1.26M(+63.2%) | -$5.62M(+5.0%) |
| Mar 2009 | - | -$769.90K(-15.0%) | -$5.36M(+1.9%) |
| Dec 2008 | - | -$905.80K(-66.3%) | -$5.26M(-1.5%) |
| Sep 2008 | -$5.27M(+234.0%) | -$2.69M(+171.7%) | -$5.34M(+40.9%) |
| Jun 2008 | - | -$990.20K(+47.4%) | -$3.79M(+24.0%) |
| Mar 2008 | - | -$671.70K(-32.0%) | -$3.06M(+19.7%) |
| Dec 2007 | - | -$987.50K(-13.4%) | -$2.55M(+61.8%) |
| Sep 2007 | -$1.58M(+6063.7%) | -$1.14M(+346.3%) | -$1.58M(+256.5%) |
| Jun 2007 | - | -$255.60K(+51.4%) | -$442.50K(+129.8%) |
| Mar 2007 | - | -$168.80K(+1272.4%) | -$192.60K(+575.8%) |
| Dec 2006 | - | -$12.30K(+112.1%) | -$28.50K(+11.3%) |
| Sep 2006 | -$25.60K(-72.1%) | -$5800.00(+1.8%) | -$25.60K(-58.6%) |
| Jun 2006 | - | -$5700.00(+21.3%) | -$61.80K(-39.3%) |
| Mar 2006 | - | -$4700.00(-50.0%) | -$101.80K(-28.7%) |
| Dec 2005 | - | -$9400.00(-77.6%) | -$142.80K(+3.9%) |
| Sep 2005 | -$91.70K(+532.4%) | -$42.00K(-8.1%) | -$137.50K(+44.0%) |
| Jun 2005 | - | -$45.70K(0.0%) | -$95.50K(+91.8%) |
| Mar 2005 | - | -$45.70K(+1014.6%) | -$49.80K(+1114.6%) |
| Dec 2004 | - | -$4100.00 | -$4100.00 |
| Sep 2004 | -$14.50K | - | - |
FAQ
- What is Anavex Life Sciences annual EBITDA?
- What is the all time high annual EBITDA for Anavex Life Sciences?
- What is Anavex Life Sciences annual EBITDA year-on-year change?
- What is Anavex Life Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Anavex Life Sciences?
- What is Anavex Life Sciences quarterly EBITDA year-on-year change?
- What is Anavex Life Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Anavex Life Sciences?
- What is Anavex Life Sciences TTM EBITDA year-on-year change?
What is Anavex Life Sciences annual EBITDA?
The current annual EBITDA of AVXL is -$43.00M
What is the all time high annual EBITDA for Anavex Life Sciences?
Anavex Life Sciences all-time high annual EBITDA is -$14.50K
What is Anavex Life Sciences annual EBITDA year-on-year change?
Over the past year, AVXL annual EBITDA has changed by +$3.53M (+7.59%)
What is Anavex Life Sciences quarterly EBITDA?
The current quarterly EBITDA of AVXL is -$12.42M
What is the all time high quarterly EBITDA for Anavex Life Sciences?
Anavex Life Sciences all-time high quarterly EBITDA is $362.10K
What is Anavex Life Sciences quarterly EBITDA year-on-year change?
Over the past year, AVXL quarterly EBITDA has changed by -$265.00K (-2.18%)
What is Anavex Life Sciences TTM EBITDA?
The current TTM EBITDA of AVXL is -$50.02M
What is the all time high TTM EBITDA for Anavex Life Sciences?
Anavex Life Sciences all-time high TTM EBITDA is -$4100.00
What is Anavex Life Sciences TTM EBITDA year-on-year change?
Over the past year, AVXL TTM EBITDA has changed by -$5.04M (-11.21%)